Wright Richard M.'s Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Jun 5, 2024
- Accession no.
- 0001415889-24-015543
- Filed
- Jun 5, 2024
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.58M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wright Richard M.CIK 0001646423 | Officer (SR. VP & CCO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | MOption exerciseAcquired | +20,625 | $2.78 | +$57,337.5 | 20,833 | Direct | |
| Jun 3, 2024 | Common Stock | MOption exerciseAcquired | +28,469 | $28.00 | +$797,132 | 49,302 | Direct | |
| Jun 3, 2024 | Common Stock | MOption exerciseAcquired | +18,375 | $22.48 | +$413,070 | 67,677 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −27,580 | $33.53 | −$924,757.4 | 40,097 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −19,264 | $33.99 | −$654,783.36 | 20,833 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | MOption exerciseDisposed | −20,625 | $0.00 | $0 | 0 | Direct | |
| Jun 3, 2024 | Common Stock | MOption exerciseDisposed | −28,469 | $0.00 | $0 | 13,531 | Direct | |
| Jun 3, 2024 | Common Stock | MOption exerciseDisposed | −18,375 | $0.00 | $0 | 23,625 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.